MAP
WVE icon

Moody Aldrich Partners’s Wave Life Sciences WVE Stock Holding History

Moody Aldrich Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-272,533
Closed -$1.98M – 222
2026
Q1 		$1.98M Sell
272,533
-1,892
-0.7% -$24.6K 0.36% 110
2025
Q4 		$4.67M Sell
274,425
-76,123
-22% -$773K 0.87% 43
2025
Q3 		$2.57M Sell
350,548
-71,304
-17% -$577K 0.49% 93
2025
Q2 		$2.74M Sell
421,852
-17,975
-4% -$119K 0.53% 77
2025
Q1 		$3.55M Buy
439,827
+41,352
+10% +$452K 0.74% 56
2024
Q4 		$4.93M Buy
398,475
+95,413
+31% +$1.27M 0.91% 38
2024
Q3 		$2.49M Buy
303,062
+123,703
+69% +$739K 0.45% 84
2024
Q2 		$895K Buy
+179,359
New +$1.02M 0.17% 116

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Moody Aldrich Partners's WVE Position: Q2 2026 in Review

Moody Aldrich Partners sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 272,533 shares — an estimated $1.98M sold.

Moody Aldrich Partners first reported a position in WVE in Q2 2024 and held it in 8 quarters. The position peaked at $4.93M in Q4 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Moody Aldrich Partners reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Moody Aldrich Partners sold 272,533 Wave Life Sciences shares in Q2 2026, an estimated $1.98M.
  • Moody Aldrich Partners first reported a position in Wave Life Sciences in Q2 2024 and held it in 8 quarters.
  • Moody Aldrich Partners's Wave Life Sciences position peaked at $4.93M in Q4 2024.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.